Also, see the Warning section
Diabetologia (2005) 48:116872
Funding The research was supported in part by Grants-in-Aid for Challenging Exploratory Research and Scientific Research (B) from the Japan Society for the Promotion of Science (JSPS KAKENHI Grant Numbers JP26660218, JP21H02347, and JP24K01911, respectively) and by grant funds from the Uehara Memorial Foundation and Ito Foundation (all to R
The advent of ~15% average weight loss drugs has, for the first time, made many clinicians more optimistic about treating obesity as a chronic condition medically
For example, drugs targeting three receptors are in developmentand their outcomes are projected to rival bariatric surgery in efficacy
A preliminary study of the physiological and perceptual effects of GLP-1 receptor agonists during alcohol consumption in people with obesity